Free Trial

Theriva Biologics (TOVX) SEC Filings & 10K Form

Theriva Biologics logo
$0.45 -0.02 (-3.32%)
Closing price 10/13/2025 04:10 PM Eastern
Extended Trading
$0.44 -0.01 (-2.97%)
As of 07:41 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Theriva Biologics SEC Filings

DateFilerForm TypeView
10/08/2025
7:00 AM
Theriva Biologics, Inc. (Filer)
Theriva Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/06/2025
3:15 PM
Theriva Biologics, Inc. (Filer)
Theriva Biologics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
10/06/2025
7:10 AM
Theriva Biologics, Inc. (Filer)
Theriva Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/04/2025
3:05 PM
Theriva Biologics, Inc. (Filer)
Theriva Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/11/2025
7:10 AM
Theriva Biologics, Inc. (Filer)
Theriva Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/11/2025
7:15 AM
Theriva Biologics, Inc. (Filer)
Theriva Biologics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/09/2025
3:50 PM
Theriva Biologics, Inc. (Filer)
Theriva Biologics (Filer)
Form DEF 14A
06/25/2025
3:01 PM
Theriva Biologics, Inc. (Filer)
Theriva Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/20/2025
3:44 PM
Theriva Biologics, Inc. (Filer)
Theriva Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/02/2025
6:00 AM
Theriva Biologics, Inc. (Filer)
Theriva Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2025
7:10 AM
Theriva Biologics, Inc. (Filer)
Theriva Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2025
7:15 AM
Theriva Biologics, Inc. (Filer)
Theriva Biologics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/08/2025
3:30 PM
Theriva Biologics, Inc. (Filer)
Theriva Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2025
8:05 AM
Theriva Biologics, Inc. (Filer)
Theriva Biologics (Filer)
Form 424B5
05/07/2025
11:15 PM
Theriva Biologics, Inc. (Filer)
Theriva Biologics (Filer)
Form EFFECT
05/07/2025
6:10 AM
Theriva Biologics, Inc. (Filer)
Theriva Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/31/2025
7:31 AM
Theriva Biologics, Inc. (Filer)
Theriva Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/21/2025
3:31 PM
Theriva Biologics, Inc. (Filer)
Theriva Biologics (Filer)
Form S-1/A
02/07/2025
3:10 PM
CVI Investments, Inc. (Filed by)
Theriva Biologics, Inc. (Subject)
Theriva Biologics (Subject)
Form SCHEDULE 13G/A
01/21/2025
3:15 PM
Theriva Biologics, Inc. (Filer)
Theriva Biologics (Filer)
Form S-1/A
12/10/2024
4:21 PM
Theriva Biologics, Inc. (Filer)
Theriva Biologics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
12/05/2024
7:10 AM
Theriva Biologics, Inc. (Filer)
Theriva Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/01/2024
3:05 PM
Theriva Biologics, Inc. (Filer)
Theriva Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2024
7:10 AM
Theriva Biologics, Inc. (Filer)
Theriva Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NYSEAMERICAN:TOVX) was last updated on 10/14/2025 by MarketBeat.com Staff
From Our Partners